Antiviral properties of two trimeric recombinant gp41 proteins
2006

Antiviral Properties of Two Recombinant Proteins Against HIV

publication Evidence: moderate

Author Information

Author(s): Delcroix-Genête Delphine, Quan Phenix-Lan, Roger Marie-Gaëlle, Hazan Uriel, Nisole Sébastien, Rousseau Cécile

Primary Institution: Institut Cochin, Department of Infectious Diseases, Paris, France

Hypothesis

Can trimeric recombinant gp41 proteins effectively inhibit HIV entry into target cells?

Conclusion

Rgp41A can inhibit HIV-1 entry by binding to gp120 and interfering with the fusion process.

Supporting Evidence

  • Rgp41A was found to inhibit both X4 and R5 isolates of HIV-1.
  • Rgp41A binds to gp120 but does not cause its dissociation.
  • Rgp41A interferes with a late step of the HIV fusion process.

Takeaway

Scientists created two proteins to stop HIV from entering cells, and one of them worked really well by blocking the virus in different ways.

Methodology

The study involved designing two recombinant proteins, Rgp41A and Rgp41B, and testing their ability to inhibit HIV-1 entry into cells.

Limitations

The study did not explore the full mechanism of action of Rgp41A and its effectiveness against all HIV strains.

Digital Object Identifier (DOI)

10.1186/1742-4690-3-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication